Process simulation study demonstrates optimized caprolactam synthesis from phenol with lower emissions and favorable economics, indicating a viable alternative to benzene routes.
This study presents a sustainable and simulation-driven production process for ε-caprolactam (CPL) using phenol as a feedstock, offering a green and economically viable alternative to conventional benzene-based routes. The process integrates three catalytic stages – Pt/SiO 2 -mediated hydrogenation, TS-1-catalyzed ammoximation, and oleum-assisted Beckmann rearrangement – all modeled and optimized in Aspen Plus. The optimized configuration achieves a CPL yield of 68 %, reduces CO 2 emissions by 30 %, and lowers total energy consumption by 12 % through integrated heat recovery. Additionally, wastewater treatment enables 60 % water reuse. Techno-economic analysis confirms commercial viability, with a Net Present Value (NPV) of BND 8.2 million and a payback period of 3.9 years for an 80,000-ton/year plant. This work delivers a validated and modular framework for CPL production aligned with circular economy principles. Future research will focus on process intensification, bio-based phenol utilization, and deployment of green hydrogen sources for full lifecycle decarbonization.
No takes yet. Share an insight, caveat, or question.
Mu'izzah et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: